| Autoimmune complications of COVID‐19 N Yazdanpanah, N Rezaei Journal of medical virology 94 (1), 54-62, 2022 | 173 | 2022 |
| Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review K Mohamed, N Yazdanpanah, A Saghazadeh, N Rezaei Bioorganic chemistry 106, 104490, 2021 | 169 | 2021 |
| The role of Toll-like receptors and neuroinflammation in Parkinson’s disease A Heidari, N Yazdanpanah, N Rezaei Journal of Neuroinflammation 19 (1), 135, 2022 | 159 | 2022 |
| Neuroinflammation and proinflammatory cytokines in epileptogenesis A Soltani Khaboushan, N Yazdanpanah, N Rezaei Molecular Neurobiology 59 (3), 1724-1743, 2022 | 149 | 2022 |
| Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19) N Yazdanpanah, A Saghazadeh, N Rezaei Reviews in the Neurosciences 31 (7), 691-701, 2020 | 70 | 2020 |
| Chronic myeloid leukemia stem cells: targeting therapeutic implications H Mojtahedi, N Yazdanpanah, N Rezaei Stem cell research & therapy 12 (1), 603, 2021 | 59 | 2021 |
| Loneliness: An Immunometabolic Syndrome H Pourriyahi, N Yazdanpanah, A Saghazadeh, N Rezaei International Journal of Environmental Research and Public Health 18 (22), 12162, 2021 | 57 | 2021 |
| Role of toll-like receptor 4 in diabetic retinopathy N Bayan, N Yazdanpanah, N Rezaei Pharmacological research 175, 105960, 2022 | 41 | 2022 |
| Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives B Abadi, N Yazdanpanah, A Nokhodchi, N Rezaei Advanced drug delivery reviews 179, 114035, 2021 | 29 | 2021 |
| Anti-inflammatory effects of GLP-1 in patients with COVID-19 S Sazgarnejad, N Yazdanpanah, N Rezaei Expert Review of Anti-infective Therapy 20 (3), 373-381, 2022 | 26 | 2022 |
| Introduction on coronavirus disease (COVID-19) pandemic: the global challenge N Rezaei, S Ashkevarian, MK Fathi, S Hanaei, Z Kolahchi, ... Coronavirus Disease-COVID-19, 1-22, 2021 | 20 | 2021 |
| Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria J Bohlen, Q Zhou, Q Philippot, M Ogishi, D Rinchai, T Nieminen, ... Cell 186 (23), 5114-5134. e27, 2023 | 19 | 2023 |
| Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines–where do we stand? MM Aliasin, N Yazdanpanah, N Rezaei Reviews in the Neurosciences 33 (7), 721-743, 2022 | 16 | 2022 |
| Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic K Mohamed, N Yazdanpanah, A Saghazadeh, N Rezaei Acta Bio Medica: Atenei Parmensis 92 (2), 2021 | 16 | 2021 |
| Natural killer cells and acute myeloid leukemia: promises and challenges S Rahmani, N Yazdanpanah, N Rezaei Cancer Immunology, Immunotherapy 71 (12), 2849-2867, 2022 | 15 | 2022 |
| The immunologic aspects of cytokine release syndrome and graft versus host disease following CAR T cell therapy V Mansouri, N Yazdanpanah, N Rezaei International Reviews of Immunology 41 (6), 649-668, 2022 | 14 | 2022 |
| Safety and efficacy of T-cell-redirecting bispecific antibodies for patients with multiple myeloma: a systematic review and meta-analysis M Noori, N Yazdanpanah, N Rezaei Cancer Cell International 23 (1), 193, 2023 | 13 | 2023 |
| Diagnostic biomarkers of dilated cardiomyopathy A Moeinafshar, N Yazdanpanah, N Rezaei Immunobiology 226 (6), 152153, 2021 | 13 | 2021 |
| Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer F Fayyaz, N Yazdanpanah, N Rezaei Cell Communication and Signaling 20 (1), 41, 2022 | 12 | 2022 |
| Interdisciplinary Approaches in Cancer Research N Yazdanpanah, N Rezaei Cancer Research: An Interdisciplinary Approach, 1-16, 2022 | 4 | 2022 |
